TITLE OF PUBLICATION

Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial

AUTHORS

Richard D.Gelber; Xin V.Wang; Bernard F.Cole; David Cameron; Fatima Cardoso; Vivianne Tjan-Heijnen; Ian Krop; Sherene Loi; Roberto Salgado; Astrid Kiermaier; Elizabeth Frank; Debora Fumagalli; Carmela Caballero; Evandro de Azambuja; Marion Procter; Emma Clark; Eleonora Restuccia; Sarah Heeson; Jose Bines; Sibylle Loiblt; Martine Piccart-Gebhart on behalf of the APHINITY Steering Committee and Investigators

PUBLICATION REFERENCE

European Journal of Cancer | Volume 166 | Issue | Page(s) 219-228 | Publication Year 2022